Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07777133 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07777133 · ClinicalTrials.gov record · last posted 2026-08-20

A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants

Name: A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants — clinical trial record (NCT07777133)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorBristol-Myers Squibb

Started2026-09-16

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy female participants

Trial Details

NCT Number	NCT07777133
Lead Sponsor	Bristol-Myers Squibb
Conditions	Healthy Female Participants
Enrollment	6 participants
Start Date	2026-09-16
Primary Completion	2026-12-05 (estimated)
Study Completion	2026-12-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-20